Technical Analysis for MYX - Mayne Pharma Group Ltd  

Grade Last Price % Change Price Change
grade C 0.525 10.53% 0.050
MYX closed up 10.53 percent on Friday, August 23, 2019, on 2.64 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical MYX trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
New Uptrend Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Earnings Movers Other 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 10.53%
180 Bearish Setup Bearish Swing Setup 12.90%

Older signals for MYX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Interactive chart
Mayne Pharma Group Limited is a specialty pharmaceutical company, which focuses on applying its drug delivery capability to commercialize branded and generic pharmaceuticals. The Company also provides contract development and manufacturing services. It operates in four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.
Health Pharmaceutical Industry Pharmaceuticals Policy Pharmaceutical Drug Delivery Pharmaceutical Industry In China Pharmaceutical Products Science And Technology In The People's Republic Of China Generic Pharmaceutical Products
Is MYX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 1.33
52 Week Low 0.44
Average Volume 5,053,087
200-Day Moving Average 0.6991
50-Day Moving Average 0.5044
20-Day Moving Average 0.488
10-Day Moving Average 0.4745
Average True Range 0.021
ADX 26.93
+DI 28.2253
-DI 18.3618
Chandelier Exit (Long, 3 ATRs ) 0.467
Chandelier Exit (Short, 3 ATRs ) 0.503
Upper Bollinger Band 0.5358
Lower Bollinger Band 0.4402
Percent B (%b) 0.89
BandWidth 19.590164
MACD Line -0.0083
MACD Signal Line -0.0121
MACD Histogram 0.0038
Fundamentals Value
Market Cap 763.3 Million
Num Shares 1.45 Billion
EPS 0.06
Price-to-Earnings (P/E) Ratio 8.61
Price-to-Sales 1.77
Price-to-Book 0.78
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.623
Resistance 3 (R3) 0.613 0.572 0.606
Resistance 2 (R2) 0.572 0.547 0.576 0.601
Resistance 1 (R1) 0.548 0.531 0.560 0.558 0.595
Pivot Point 0.507 0.507 0.513 0.511 0.507
Support 1 (S1) 0.483 0.482 0.495 0.493 0.455
Support 2 (S2) 0.442 0.466 0.446 0.449
Support 3 (S3) 0.418 0.442 0.444
Support 4 (S4) 0.428